Reaction

Renal Transplant reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,563 reports · 88 co-occurring drugs

As of the last recalculation, Renal Transplant appears in 3,563 FAERS reports alongside 88 co-occurring drug terms. The strongest observed disproportionality signal is PARICALCITOL (PRR 72.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Paricalcitol	168	72.9	73.7
Agalsidase Beta	85	55.0	55.5
Tolvaptan	107	44.3	44.6
Epoetin Alfa	64	32.1	32.3
Mycophenolic Acid	128	24.2	24.3
Patiromer	56	24.0	24.1
Valganciclovir	71	22.4	22.5
Valganciclovir Hydrochloride	71	22.4	22.5
Tacrolimus	504	21.7	21.8
Darbepoetin Alfa	182	20.7	20.8
Eculizumab	174	19.6	19.7
Calcitriol Capsules 0.25 Mcg	64	19.0	19.0
Calcitriol Capsules 0.5 Mcg	64	19.0	19.0
Calcitriol	64	18.8	18.8
Cinacalcet Hydrochloride	143	18.6	18.7
Sevelamer Carbonate	36	18.5	18.5
Mycophenilic Acid	63	18.1	18.1
Sodium Bicarbonate	67	17.1	17.2
Sodium Bicarbonate Injection,	67	17.1	17.2
Erythropoietin	55	15.9	15.9
Valganciclovir Hydrochloride Powder,	30	14.5	14.5
Ravulizumab	33	14.4	14.4
Abacavir Sulfate	22	13.3	13.3
Anti-Thymocyte Globulin (Rabbit)	18	13.1	13.1
Tacrolimus Extended-Release Capsules	232	11.5	11.6
Tacrolimus Ointment 0.1%	230	11.5	11.5
Raltegravir	32	11.4	11.4
Insulin Aspart	121	11.0	11.1
Human Insulin	22	10.3	10.4
Mycophenolate Mofetil	217	9.9	9.9
Mycophenolate Mofetil Hydrochloride	217	9.9	9.9
Dolutegravir Sodium	14	9.1	9.1
Insulin Human	60	9.0	9.0
Entecavir	17	8.5	8.6
Daspone	14	8.4	8.4
Dapsone Gel, 5%	14	8.4	8.4
Tenofovir Disoproxil Fumarate	47	8.4	8.4
Iron Sucrose	13	8.0	8.0
Dapsone	14	7.7	7.7
Labetalol	17	7.5	7.5
Sirolimus	16	7.0	7.0
Glecaprevir And Pibrentasvir	13	6.9	6.9
Methoxy Polyethylene Glycol-Epoetin Beta	13	6.9	6.9
Insulin Glargine-Yfgn	25	6.7	6.7
Cyclosporine	117	6.3	6.3
Lamivudine	33	6.3	6.3
Atazanavir	15	6.1	6.1
Tenofovir Disoproxil Fumarate Tablets	9	6.1	6.1
Basiliximab	12	6.0	6.0
Atovaquone	8	5.8	5.8
Clonidine	49	5.7	5.7
Lansoprazole	165	5.6	5.6
Nifedipine	44	5.5	5.5
Ritonavir	27	5.4	5.4
Insulin Glargine	213	5.3	5.3
Sulfamethoxazole And Trimethoprim	75	5.3	5.3
Insulin Glulisine	9	5.2	5.2
Nystatin Ointment	23	5.2	5.2
Nystatin Cream	23	5.1	5.1
Drs. Clotrimazole	10	5.1	5.1
Family Wellness Clotrimazole	10	5.1	5.1
Clotrimazole Topical	10	5.1	5.1
Insulin Degludec	20	5.0	5.0
Insulin Lispro	114	4.9	4.9
Clotrimazole	10	4.8	4.8
Darunavir	12	4.6	4.7
Emtricitabine And Tenofovir Alafenamide	9	4.6	4.6
Esomeprazole	48	4.6	4.6
Emtricitabine And Tenofovir Disoproxil Fumarate	31	4.0	4.0
Pancrelipase	26	4.0	4.0
Lopinavir And Ritonavir	9	3.9	3.9
Ivacaftor	5	3.7	3.7
Loperamide Hcl	8	3.6	3.6
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	11	3.6	3.6
Risankizumab-Rzaa	45	3.2	3.2
Macitentan	34	2.9	2.9
Somatropin	35	2.8	2.8
Minoxidil Foam 5% (Womens)	15	2.7	2.7
Ambrisentan	54	2.5	2.6
Romiplostim	6	2.3	2.3
Rifaximin	8	2.2	2.2
Tafamidis	4	2.0	2.0
Minoxidil	15	2.0	2.0
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate	3	1.9	1.9
Elexacaftor, Tezacaftor, And Ivacaftor	4	1.9	1.9
Velpatasvir And Sofosbuvir	4	1.8	1.8
Aflibercept	7	1.3	1.3
Evolocumab	19	0.7	0.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.